AU2002363841A8 - Test system for identifying or testing active substances, which affect the growth and/or the survival of nerve cells - Google Patents
Test system for identifying or testing active substances, which affect the growth and/or the survival of nerve cellsInfo
- Publication number
- AU2002363841A8 AU2002363841A8 AU2002363841A AU2002363841A AU2002363841A8 AU 2002363841 A8 AU2002363841 A8 AU 2002363841A8 AU 2002363841 A AU2002363841 A AU 2002363841A AU 2002363841 A AU2002363841 A AU 2002363841A AU 2002363841 A8 AU2002363841 A8 AU 2002363841A8
- Authority
- AU
- Australia
- Prior art keywords
- survival
- identifying
- growth
- affect
- test system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000013543 active substance Substances 0.000 title 1
- 210000002569 neuron Anatomy 0.000 title 1
- 230000004083 survival effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Physiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2001164556 DE10164556A1 (en) | 2001-12-14 | 2001-12-14 | Test system for the search or testing of active substances that influence the growth and / or survival of nerve cells |
DE10164556.2 | 2001-12-14 | ||
PCT/DE2002/004686 WO2003052415A2 (en) | 2001-12-14 | 2002-12-13 | Test system for identifying or testing active substances, which affect the growth and/or the survival of nerve cells |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002363841A1 AU2002363841A1 (en) | 2003-06-30 |
AU2002363841A8 true AU2002363841A8 (en) | 2003-06-30 |
Family
ID=7711197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002363841A Abandoned AU2002363841A1 (en) | 2001-12-14 | 2002-12-13 | Test system for identifying or testing active substances, which affect the growth and/or the survival of nerve cells |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1459074A2 (en) |
AU (1) | AU2002363841A1 (en) |
DE (1) | DE10164556A1 (en) |
WO (1) | WO2003052415A2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1133993A1 (en) * | 2000-03-10 | 2001-09-19 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Substances for the treatment of spinal muscular atrophy |
JP2002101890A (en) * | 2000-09-29 | 2002-04-09 | Inst Of Physical & Chemical Res | Rna-binding protein |
-
2001
- 2001-12-14 DE DE2001164556 patent/DE10164556A1/en not_active Ceased
-
2002
- 2002-12-13 WO PCT/DE2002/004686 patent/WO2003052415A2/en not_active Application Discontinuation
- 2002-12-13 EP EP02798293A patent/EP1459074A2/en not_active Withdrawn
- 2002-12-13 AU AU2002363841A patent/AU2002363841A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1459074A2 (en) | 2004-09-22 |
AU2002363841A1 (en) | 2003-06-30 |
DE10164556A1 (en) | 2003-07-03 |
WO2003052415A2 (en) | 2003-06-26 |
WO2003052415A3 (en) | 2003-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003900780A0 (en) | Analysis system and procedure | |
EP1390747A4 (en) | Systems and methods for automated analysis of cells and tissues | |
ZA200500091B (en) | System and method for the preparation of arrays of biological or other molecules | |
AU2003296945A1 (en) | Device and method for in-line blood testing using biochips | |
AU2002367597A1 (en) | System, method and apparatus for the rapid detection and analysis of airborne biological agents | |
IL150989A0 (en) | Systems, apparatuses and methods for diamond color measurement and analysis | |
AU3227400A (en) | Flow cell, analyte measurement apparatus and methods related thereto | |
MXPA02005234A (en) | Methods for automatically monitoring analyte concentration using minimally invasive devices. | |
AU2003214863A1 (en) | Test and burn-in connector | |
WO2002099075A3 (en) | Prmts as modifiers of the p53 pathway and methods of use | |
IL139567A0 (en) | Quantitative methods, systems and apparatuses for gene expression analysis | |
GB0109765D0 (en) | Apparatus and method for determining the viability of eggs | |
WO2003003004A3 (en) | Method for identifying compounds the specifically deplete mast cells | |
WO2001075178A3 (en) | Methods for identifying peptide aptamers capable of altering a cell phenotype | |
AU2001225804A1 (en) | Improved test structures and methods for inspecting and utilizing the same | |
MXPA01011182A (en) | Methods, compositions and kits for biological indicator of sterilization. | |
AU2002247097A1 (en) | Activity based probe analysis | |
AU2003270037A1 (en) | Methods for measuring kinase activity and phosphatase activity | |
AU2003260792A1 (en) | Method and apparatus for determining the viability of eggs | |
DE60234250D1 (en) | Device for cell or tissue culture | |
AU2003251289A8 (en) | Methods and systems for the prediction of the biological function of biopolymers | |
WO2004099364A3 (en) | Multicellular compositions of pluripotent human embryonic stem cells and cancer cells | |
EP1468265A4 (en) | Systems and methods for the analysis of protein phosphorylation | |
AU2002363841A8 (en) | Test system for identifying or testing active substances, which affect the growth and/or the survival of nerve cells | |
CA2479749A1 (en) | Test system for evaluating the compatibility of biologically active substances with copolymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |